Clinical Trials Directory

Trials / Completed

CompletedNCT01304264

Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations in Glaucoma Patients

Comparison of Intraocular Pressure, Blood Pressure, Ocular Perfusion and Blood Flow Fluctuations During the Addition of Dorzolamid vs Timolol in Glaucoma Subjects Treated With Prostaglandin Analogue Monotherapy

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
Lithuanian University of Health Sciences · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To evaluate whether add-on to prostaglandin therapy with twice a day (bid) dorzolamide is statistically superior to twice a day (bid) timolol with regard to increasing ocular blood flow

Detailed description

Hypotensive treatments for glaucomatous optic neuropathy (GON), depending on their chemical composition can influence the ocular circulation independent of intraocular pressure (IOP) reduction. It is therefore important not only to identify ocular blood flow deficits in GON, but also document the influence of GON treatments on the ocular circulation

Conditions

Interventions

TypeNameDescription
DEVICEColor Doppler ImagingColor Doppler imaging (CDI) system for measurements of blood flow in the ophthalmic (OA), central retinal (CRA), and nasal (NPCA) and temporal (TPCA) posterior ciliary arteries. In each vessel, peak systolic velocity (PSV) and end diastolic velocity (EDV) were determined, and Pourcelot's resistive index will be calculated (RI = (PSV-EDV)/PSV).

Timeline

Start date
2011-03-01
Primary completion
2011-09-01
Completion
2011-11-01
First posted
2011-02-25
Last updated
2012-01-12

Locations

1 site across 1 country: Lithuania

Source: ClinicalTrials.gov record NCT01304264. Inclusion in this directory is not an endorsement.